Open AccessMedicine

J. Singh, K. Saag, S. L. Bridges, E. Akl, Raveendhara R. Bannuru, M. Sullivan, E. Vaysbrot, Christine McNaughton, M. Osani, R. Shmerling, J. Curtis, D. Furst, D. Parks, A. Kavanaugh, J. O'dell, Charles King, Amye Leong, E. Matteson, J. Schousboe, B. Drevlow, S. Ginsberg, J. Grober, E. St.clair, E. Tindall, Amy S. Miller, T. McAlindon

2016.1.1ARTHRITIS CARE & RESEARCH

DOI: 10.1002/acr.22783

tlooto Summary

To develop a new evidence‐based, pharmacologic treatment guideline for rheumatoid arthritis (RA), a large number of patients with RA are referred to a single clinic for treatment with these medications.

Abstract

To develop a new evidence‐based, pharmacologic treatment guideline for rheumatoid arthritis (RA).

Citation format

SINGH, J., et al. 2015 american college of rheumatology guideline for the treatment of rheumatoid arthritis. ARTHRITIS CARE & RESEARCH, 2016, 68.